STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York

MONROVIA, Calif., Oct. 27 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced today that Deborah Andrews, Chief Financial Officer, will present at the 20th Annual Oppenheimer Healthcare Conference at The Waldorf-Astoria Hotel on Wednesday, November 4th at 3:55 p.m. Eastern Time.

Interested parties can access a live audio web cast of the presentation at www.staar.com. A replay of the presentation will be available at the same location.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian® ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer® is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at www.staar.com.

    CONTACT:   Investors                         Media
               EVC Group                         EVC Group
               Douglas Sherk, 415-896-6820       Chris Gale 646-201-5431
               Mike Pollock, 415-896-6820

SOURCE STAAR Surgical Company